Reports
Reports
The global acne medication market reached a value of about USD 9.66 billion in 2023. The market for acne medication is being driven by the growing prevalence of acne disorders and the popularity of retinoids. The market is further expected to grow at a CAGR of 4.2% in the forecast period of 2024-2032 to attain nearly USD 12.38 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Acne medication market expansion is being fuelled by an increase in the global prevalence of acne disorders. Teenagers' adoption of unhealthy lifestyles and the growing acceptance of skin care products are two key aspects driving the market growth. In addition, the availability and awareness of a wide range of products containing antibiotic agents, such as lotions, creams, and gels, as well as the additional benefits associated with their use, would boost the demand for acne medicine. Acne is becoming more common due to a variety of factors, including poor lifestyles, diets, smoking, hormonal changes, and excessive sebum secretion, among others. Furthermore, a dermatological survey found that the number of persons affected by acne is significant in westernised countries, including the North America region.
Acne, also known as acne vulgaris, is a common skin disorder caused mostly by changes in skin structure. Millions of adolescents all over the world suffer from acne. Pimples, blackheads, greasy skin, and scarring are all symptoms. There are two types of acne, namely, non-inflammatory and inflammatory. Inflammatory acne takes longer to heal and can leave lasting scars on the skin. It usually affects areas of the body with a large number of sweat glands, such as the upper chest, back, and face. Acne medicines are pharmaceuticals that are used to treat acne.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on therapeutic class, the market is divided into:
On the basis of formulation, the market is categorised into:
The market is segmented based on type into:
By acne type, the market is bifurcated into:
Based on distribution channel, the market is divided into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
There has been a rise in the popularity of retinoids to treat acne. Retinoids accounted for a significant share of the acne medication industry in 2020, owing to their great efficacy in treating moderate to severe acne and their ability to clear pores, allowing other treatments to work correctly. Acne's microcomedo–precursor lesion is the focus of topical retinoids. Based on the severity of acne, retinoids are typically used as a first-line treatment, either alone or in combination with other medicines. They are commonly used to treat severe inflammatory acne and are also a popular choice for maintenance therapy. Retinoids also diminish microcomedones and follicular obstruction in both non-inflammatory and inflammatory acne. These factors are expected to aid the industry growth in the forecast period.
The report gives a detailed analysis of the following key players in the global acne medication market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Therapeutic Class, Formulation, Type, Acne Type, Distribution Channel, Region |
Breakup by Therapeutic Class | Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Others |
Breakup by Formulation | Topical Medications, Oral Medications |
Breakup by Type | Prescription Medication, Over-The-Counter Medication |
Breakup by Acne Type | Non-Inflammatory Acne, Inflammatory Acne |
Breakup by Distribution Channel | Retail Stores, Pharmacies, Online |
Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Almirall S.A, Bausch Health Companies Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Galderma S.A., Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Application
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Acne Medication Market Analysis
8.1 Key Industry Highlights
8.2 Global Acne Medication Historical Market (2018-2023)
8.3 Global Acne Medication Market Forecast (2024-2032)
8.4 Global Acne Medication Market by Therapeutic Class
8.4.1 Retinoids
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Antibiotics
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Salicylic Acid
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.4 Benzoyl Peroxide
8.4.4.1 Historical Trend (2018-2023)
8.4.4.2 Forecast Trend (2024-2032)
8.4.5 Others
8.5 Global Acne Medication Market by Formulation
8.5.1 Topical Medications
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Oral Medications
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.6 Global Acne Medication Market by Type
8.6.1 Prescription Medication
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Over-The-Counter Medication
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.7 Global Acne Medication Market by Acne Type
8.7.1 Non-Inflammatory Acne
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Inflammatory Acne
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.8 Global Acne Medication Market by Distribution Channel
8.8.1 Retail Stores
8.8.1.1 Historical Trend (2018-2023)
8.8.1.2 Forecast Trend (2024-2032)
8.8.2 Pharmacies
8.8.2.1 Historical Trend (2018-2023)
8.8.2.2 Forecast Trend (2024-2032)
8.8.3 Online
8.8.3.1 Historical Trend (2018-2023)
8.8.3.2 Forecast Trend (2024-2032)
8.9 Global Acne Medication Market by Region
8.9.1 North America
8.9.1.1 Historical Trend (2018-2023)
8.9.1.2 Forecast Trend (2024-2032)
8.9.2 Europe
8.9.2.1 Historical Trend (2018-2023)
8.9.2.2 Forecast Trend (2024-2032)
8.9.3 Asia Pacific
8.9.3.1 Historical Trend (2018-2023)
8.9.3.2 Forecast Trend (2024-2032)
8.9.4 Latin America
8.9.4.1 Historical Trend (2018-2023)
8.9.4.2 Forecast Trend (2024-2032)
8.9.5 Middle East and Africa
8.9.5.1 Historical Trend (2018-2023)
8.9.5.2 Forecast Trend (2024-2032)
9 North America Acne Medication Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Acne Medication Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Acne Medication Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.2 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Acne Medication Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Acne Medication Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Almirall, S.A
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Bausch Health Companies Inc.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 GlaxoSmithKline plc.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Johnson & Johnson Services, Inc.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Galderma S.A.
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Acne Medication Market: Key Industry Highlights, 2018 and 2032
2. Global Acne Medication Historical Market: Breakup by Therapeutic Class (USD Billion), 2018-2023
3. Global Acne Medication Market Forecast: Breakup by Therapeutic Class (USD Billion), 2024-2032
4. Global Acne Medication Historical Market: Breakup by Formulation (USD Billion), 2018-2023
5. Global Acne Medication Market Forecast: Breakup by Formulation (USD Billion), 2024-2032
6. Global Acne Medication Historical Market: Breakup by Type (USD Billion), 2018-2023
7. Global Acne Medication Market Forecast: Breakup by Type (USD Billion), 2024-2032
8. Global Acne Medication Historical Market: Breakup by Acne Type (USD Billion), 2018-2023
9. Global Acne Medication Market Forecast: Breakup by Acne Type (USD Billion), 2024-2032
10. Global Acne Medication Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2023
11. Global Acne Medication Market Forecast: Breakup by Distribution Channel (USD Billion), 2024-2032
12. Global Acne Medication Historical Market: Breakup by Region (USD Billion), 2018-2023
13. Global Acne Medication Market Forecast: Breakup by Region (USD Billion), 2024-2032
14. North America Acne Medication Historical Market: Breakup by Country (USD Billion), 2018-2023
15. North America Acne Medication Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Europe Acne Medication Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Europe Acne Medication Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Asia Pacific Acne Medication Historical Market: Breakup by Country (USD Billion), 2018-2023
19. Asia Pacific Acne Medication Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Latin America Acne Medication Historical Market: Breakup by Country (USD Billion), 2018-2023
21. Latin America Acne Medication Market Forecast: Breakup by Country (USD Billion), 2024-2032
22. Middle East and Africa Acne Medication Historical Market: Breakup by Country (USD Billion), 2018-2023
23. Middle East and Africa Acne Medication Market Forecast: Breakup by Country (USD Billion), 2024-2032
24. Global Acne Medication Market Structure
In 2023, the market attained a value of approximately USD 9.66 billion.
The market is projected to grow at a CAGR of 4.2% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 12.38 billion by 2032.
The major drivers of the market include the increasing cases of acne disorders and rapid advancements in treatment technology and medication.
The key trends of the market include the rising popularity of retinoids and the growing concern for facial aesthetics.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant therapeutic classes of acne medication in the market are retinoids, antibiotics, salicylic acid, and benzoyl peroxide, among others.
The major formulations in the market include topical medications and oral medications.
The significant types of acne medication available in the market are prescription medication and over-the-counter medication.
The dominant acne types are non-inflammatory acne and inflammatory acne.
The significant distribution channels of acne medication include retail stores, pharmacies, and online.
The key players in the global acne medication market are Almirall S.A, Bausch Health Companies Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., and Galderma S.A., among others.
The global acne medication market attained a value of nearly USD 9.66 billion in 2023, driven by the rising prevalence of acne disorders and the growing advancements in developing acne treatment solutions. Aided by the growing popularity of retinoids and the increasing prevalence of inflammatory acne, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 4.2%. The market is projected to reach USD 12.38 billion by 2032.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on therapeutic class, the acne medication industry can be segmented into retinoids, antibiotics, salicylic acid, and benzoyl peroxide, among others. By formulation, the market can be bifurcated into topical medications and oral medications. Based on type, the market has been segmented into prescription medication and over-the-counter medication. By acne type, the industry has been broadly categorised into non-inflammatory acne and inflammatory acne. On the basis of distribution channel, the industry can be divided into retail stores, pharmacies, and online. The major regional markets for acne medication are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Almirall S.A, Bausch Health Companies Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., and Galderma S.A., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.